Metanomics Health GmbH - Product Pipeline Analysis, 2018 Update

Metanomics Health GmbH - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME341424PD
  • |
  • Pages: 26
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Metanomics Health GmbH (Metanomics), a subsidiary of BASF SE, is a biotech company that provides metabolic biomarker identification and validation solutions. The company offers analysis of metabolites for various applications in pharma and biotech, biobanking, academia, food and feed industry and diagnostics fields. It develops novel biomarkers for early asymptomatic heart failure and type-2 diabetes. The company's products include MxP global profiling, MxP targeted profiling, MxP isotope tracer, MxP catecholamines and steroids, MxP biofluids quality control and diagnostic type assays. It conducts biomarker program, which include development of new diagnostic metabolic biomarkers; co-development of companion diagnostic biomarkers; development of metabolic biomarkers; and identification and validation of new drug targets. The company operates in Japan and the US. Metanomics is headquartered in Berlin, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Metanomics Health GmbH

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Metanomics Health GmbH Company Overview 4

Metanomics Health GmbH Company Snapshot 4

Metanomics Health GmbH Pipeline Products and Ongoing Clinical Trials Overview 4

Metanomics Health GmbH - Pipeline Analysis Overview 6

Metanomics Health GmbH - Key Facts 6

Metanomics Health GmbH - Major Products and Services 7

Metanomics Health GmbH Pipeline Products by Development Stage 8

Metanomics Health GmbH Pipeline Products Overview 10

Diagnostic Assay - Multiple Sclerosis 10

Diagnostic Assay - Multiple Sclerosis Product Overview 10

Diagnostic Assay - Pancreatic Cancer 11

Diagnostic Assay - Pancreatic Cancer Product Overview 11

Diagnostic Assay - NSCLC 12

Diagnostic Assay - NSCLC Product Overview 12

Diagnostic Assay - Congestive Heart Failure 13

Diagnostic Assay - Congestive Heart Failure Product Overview 13

Diagnostic Assay - Non-Alcoholic Steatohepatitis 14

Diagnostic Assay - Non-Alcoholic Steatohepatitis Product Overview 14

Diagnostic Assay - Type 2 Diabetes 15

Diagnostic Assay - Type 2 Diabetes Product Overview 15

Diagnostic Assay - Type 2 Diabetes Risk 16

Diagnostic Assay - Type 2 Diabetes Risk Product Overview 16

Prognostic Assay - Prostate Cancer 17

Prognostic Assay - Prostate Cancer Product Overview 17

Prognostic Assay - Congestive Heart Failure 18

Prognostic Assay - Congestive Heart Failure Product Overview 18

Metanomics Health GmbH - Key Competitors 19

Metanomics Health GmbH - Key Employees 20

Metanomics Health GmbH - Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 22

Metanomics Health GmbH, Recent Developments 22

Jun 03, 2016: BASF Hires PwC to Explore Strategic Options For Metanomics Health 22

Aug 26, 2014: Cenix BioScience and Metanomics Health sign research agreement 22

Appendix 23

Methodology 23

About GlobalData 26

Contact Us 26

Disclaimer 26

List of Figures

Metanomics Health GmbH Pipeline Products by Equipment Type 5

Metanomics Health GmbH Pipeline Products by Development Stage 8

List of Tables

Metanomics Health GmbH Pipeline Products and Ongoing Clinical Trials Overview 4

Metanomics Health GmbH Pipeline Products by Equipment Type 5

Metanomics Health GmbH Pipeline Products by Indication 5

Metanomics Health GmbH, Key Facts 6

Metanomics Health GmbH, Major Products and Services 7

Metanomics Health GmbH Number of Pipeline Products by Development Stage 8

Metanomics Health GmbH Pipeline Products Summary by Development Stage 9

Diagnostic Assay - Multiple Sclerosis - Product Status 10

Diagnostic Assay - Multiple Sclerosis - Product Description 10

Diagnostic Assay - Pancreatic Cancer - Product Status 11

Diagnostic Assay - Pancreatic Cancer - Product Description 11

Diagnostic Assay - NSCLC - Product Status 12

Diagnostic Assay - NSCLC - Product Description 12

Diagnostic Assay - Congestive Heart Failure - Product Status 13

Diagnostic Assay - Congestive Heart Failure - Product Description 13

Diagnostic Assay - Non-Alcoholic Steatohepatitis - Product Status 14

Diagnostic Assay - Non-Alcoholic Steatohepatitis - Product Description 14

Diagnostic Assay - Type 2 Diabetes - Product Status 15

Diagnostic Assay - Type 2 Diabetes - Product Description 15

Diagnostic Assay - Type 2 Diabetes Risk - Product Status 16

Diagnostic Assay - Type 2 Diabetes Risk - Product Description 16

Prognostic Assay - Prostate Cancer - Product Status 17

Prognostic Assay - Prostate Cancer - Product Description 17

Prognostic Assay - Congestive Heart Failure - Product Status 18

Prognostic Assay - Congestive Heart Failure - Product Description 18

Metanomics Health GmbH, Key Employees 20

Metanomics Health GmbH, Other Locations 21

Glossary 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Pharmacelsus GmbH

Pharis Biotec GmbH

Sphingotec GmbH

Metanomics Health GmbH, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 54413
Site License
USD 1500 INR 108825
Corporate User License
USD 2250 INR 163238

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com